Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 2,893-2,904 of 10,592
Drug study icon
CompletedNCT02282761

A study to Assess the Antipsychotic Efficacy of ITI-007

This study exists to compare options and see whether the medication ITI-007 offers something meaningfully different. Researchers are trying to understand what the medication ITI-007 could change in day-to-day care and decision-making.

In United States
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
United States
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT02469155

A study to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment

This study exists to compare options and see whether the medication ITI-007 offers something meaningfully different. Researchers are trying to understand what the medication ITI-007 could change in day-to-day care and decision-making.

In United States
SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT04398225

A study to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine in Pediatric Subjects With Attention-deficit/Hyperactivity Disorder

This study exists to better understand the safety of this type of care and how manageable it feels in practice. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.

In United States
ADHDDrugFrom 4 Years to 12 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
Drug study icon
CompletedNCT03605836

A study Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.

In United States
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
Drug study icon
CompletedNCT03287869

Brexpiprazole for Bipolarity

This study is completed in the United States, in Bulgaria, in Croatia, .... It is testing brexpiprazole for Bipolarity.

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
Drug study icon
TerminatedNCT03643159

A study to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolarity type I, and Major Depressive Disorder

This study was terminated in the United States. It focuses on depression.

Remote / online
Depression, Bipolarity, ...DrugFrom 18 Years to 63 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Depression, Bipolarity, ...
Drug study icon
CompletedNCT07305779

A study to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and Women

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

In United States
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.